KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Amgen (AMGN) Income from Continuing Operations (2016 - 2026)

Amgen has reported Income from Continuing Operations over the past 18 years, most recently at 1819000000.0 for Q1 2026.

  • For Q1 2026, Income from Continuing Operations rose 5.14% year-over-year to 1819000000.0; the TTM value through Mar 2026 reached 7800000000.0, up 31.47%, while the annual FY2025 figure was 7711000000.0, 88.53% up from the prior year.
  • Income from Continuing Operations for Q1 2026 was 1819000000.0 at Amgen, up from 1333000000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 3216000000.0 in Q3 2025 and troughed at 113000000.0 in Q1 2024.
  • A 5-year average of 1581705882.35 and a median of 1476000000.0 in 2022 define the central range for Income from Continuing Operations.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 103.98% in 2024 and later surged 1630.97% in 2025.
  • Year by year, Income from Continuing Operations stood at 1616000000.0 in 2022, then plummeted by 52.54% to 767000000.0 in 2023, then fell by 18.25% to 627000000.0 in 2024, then surged by 112.6% to 1333000000.0 in 2025, then skyrocketed by 36.46% to 1819000000.0 in 2026.
  • Business Quant data shows Income from Continuing Operations for AMGN at 1819000000.0 in Q1 2026, 1333000000.0 in Q4 2025, and 3216000000.0 in Q3 2025.